(3) Department of Data Management,
Jules Bordet Institute, 1 Rue Heger-Bordet, 1000 Brussels, Belgium
The Nobel Prize in Physiology or Medicine was awarded jointly to Albert Claude, formerly of the Rockefeller Institute and currently director of the Institute
Jules Bordet in Belgium, Emil Palade of Yale University Medical School, and Christian de Duve of Belgium, associated with the Rockefeller Institute and the University of Louvain, for their research into the inner workings of cells.
This poster presentation, with the title 'A first-in-class, first-in-human phase I/IIa trial of CAN04, targeting Interleukin-1 Receptor Accessory Protein (IL1RAP), in patients with solid tumours', was given by the coordinating investigator Professor Ahmad Awada, Institut
Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium.
The study involved a cohort of 220 consecutive patients, with no prior history of prostate cancer, who underwent prostate biopsy due to an abnormal PSA and/or DRE in Urology Department at
Jules Bordet Institute between January 2009 and August 2011.
Azim, Jr., a Fellow at the Department of Medical Oncology at the Institute
Jules Bordet (Brussels, Belgium), and colleagues in Italy analysed results from 14 trials that had taken place between 1970 and 2009, involving 1,417 pregnant women with a history of breast cancer and 18,059 women with a history of breast cancer who were not pregnant.
Martine Piccart-Gebhart, head of the medicine department of the Institut
Jules Bordet in Brussels, said the combination therapy is not yet ready for prime time.
This poster presentation, with the title 'A first-in-class, first-in-human phase I/IIa trial of CAN04, targeting Interleukin-1 Receptor Accessory Protein (IL1RAP), in patients with solid tumours', will be given by the coordinating investigator Professor Ahmad Awada, Institut
Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium.
"The year 2005 sees the first real, indisputable evidence that tanning bed use contributes to melanoma risk," said Philippe Autier, M.D., of the
Jules Bordet Institute, Brussels, the chair of the session at which the studies were presented.
A physician by training, Dr Lehmann started his academic career at the Ludwig Institute for Cancer Research in Brussels, followed by a position at the Institute
Jules Bordet. He then moved to the European Organisation for Research and Treatment of Cancer (EORTC) as medical advisor.